Literature DB >> 18282120

Proteomics: advances in biomarker discovery.

Matthew L Cowan1, Jaime Vera.   

Abstract

The challenges encountered by proteomic researchers seeking diagnostic, prognostic and mechanistic markers were the subject of the 1-day meeting, Proteomics: Advances in Biomarker Discovery hosted by EuroSciCon. The speakers had a broad range of clinical and basic science interests, and presented data using a number of proteomic platforms to search for discriminant biomarkers of disease in easily accessible bodily fluids including serum and urine. Several potential pitfalls for proteomic researchers were mentioned and the potential of collaborative networks between research institutions to increase the size and power of clinical studies was discussed. Overall, the meeting highlighted the exciting opportunities that proteomic techniques offer for discovering not only diagnostic but also prognostic and mechanistic markers of a number of clinically important diseases.

Mesh:

Substances:

Year:  2008        PMID: 18282120     DOI: 10.1586/14789450.5.1.21

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  9 in total

Review 1.  Finding biomarkers is getting easier.

Authors:  Brian Patrick Bradley
Journal:  Ecotoxicology       Date:  2012-03-13       Impact factor: 2.823

2.  Proteomic Interrogation in Cancer Biomarker.

Authors:  Un-Beom Kang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Chemometrics of differentially expressed proteins from colorectal cancer patients.

Authors:  Lay-Chin Yeoh; Saravanan Dharmaraj; Boon-Hui Gooi; Manjit Singh; Lay-Harn Gam
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

4.  Changes in liver proteome expression of Senegalese sole (Solea senegalensis) in response to repeated handling stress.

Authors:  Odete D Cordeiro; Tomé S Silva; Ricardo N Alves; Benjamin Costas; Tune Wulff; Nadège Richard; Mahaut de Vareilles; Luís E C Conceição; Pedro M Rodrigues
Journal:  Mar Biotechnol (NY)       Date:  2012-02-12       Impact factor: 3.619

5.  Comparative proteomics analysis of human gastric cancer.

Authors:  Wei Li; Jian-Fang Li; Ying Qu; Xue-Hua Chen; Jian-Min Qin; Qin-Long Gu; Min Yan; Zheng-Gang Zhu; Bing-Ya Liu
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

6.  Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Authors:  Kai Wang; Shile Zhang; Bruz Marzolf; Pamela Troisch; Amy Brightman; Zhiyuan Hu; Leroy E Hood; David J Galas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

7.  Potential metabolite markers of schizophrenia.

Authors:  J Yang; T Chen; L Sun; Z Zhao; X Qi; K Zhou; Y Cao; X Wang; Y Qiu; M Su; A Zhao; P Wang; P Yang; J Wu; G Feng; L He; W Jia; C Wan
Journal:  Mol Psychiatry       Date:  2011-10-25       Impact factor: 15.992

8.  Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry.

Authors:  Wanchang Cui; Jinfang Ma; Yulei Wang; Shyam Biswal
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  An Exploration of Molecular Correlates Relevant to Radiation Combined Skin-Burn Trauma.

Authors:  Aminul Islam; Svetlana Ghimbovschi; Min Zhai; Joshua M Swift
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.